Søgning på udtrykket 'mrsa' giver 48 resultater
Dokumenter [6] Sider [2] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]
Dokumenter [6]
Udgivet af Sundhedsstyrelsen, 3. udgave
Udgivet af Sundhedsstyrelsen. Findes også på www.sst.dk/-/media/Udgivelser/2016/Vejledning-om-MRSA-270916/Information-om-behandling-af-MRSA-b%C3%A6rertilstand.ashx
DANMAP-rapporten, der beskriver antibiotikaforbrug og resistensudviklingen i Danmark, udgives af DTU Fødevareinstituttet, DTU Veterinærinstituttet og Statens Serum Institut.
DANMAP-rapporten, der beskriver antibiotikaforbrug og resistensudviklingen i Danmark, udgives af DTU Fødevareinstituttet, DTU Veterinærinstituttet og Statens Serum Institut.
DANMAP-rapporten, der beskriver antibiotikaforbrug og resistensudviklingen i Danmark, udgives af DTU Fødevareinstituttet, DTU Veterinærinstituttet og Statens Serum Institut.
DANMAP-rapporten, der beskriver antibiotikaforbrug og resistensudviklingen i Danmark, udgives af DTU Fødevareinstituttet, DTU Veterinærinstituttet og Statens Serum Institut.
Sider [2]
…er / Pernille Ravn. 09.00-09.15 Erysipelas. Hvilken behandling er bedst? / Gruppe 5. 09.15-09.30 Strategi ved bid fra dyr / Gruppe 6. 09.30-09.45 Sammenfatning erysipelas / Pernille Ravn. 09.45-09.50 Strække ben pause. 09.50-10.00 Intro til MRSA. Præsentation af patientcase / Lotte Ebdrup. 10.00-10.45 (MR)SA ? epidemiologi, patogenese i forhold til hud og knogler / Robert Skov. 10.45-11.00 Kaffe/te ? pause. 11.00-11.20 Spondylodiskitis ? antibiotisk behandling / Gruppe 7. 11.20-12…
… 13.45 – 14.00. Pause. 14.00 – 14.45. Behandling af urinvejsinfektion set fra KMA. Afdelingslæge Frederik Hertz, KMA, RH. 14.45 – 15.00. Kaffe og kage og frugt. 15.00 – 15.35. Bogstavbakterierne - MRSA, CPO, ESBL, VRE – forebyggelse og behandling. Afdelingslæge Frederik Hertz, KMA, RH. 15.35 – 15.45. Evaluering. Overlæge Rikke Krogh-Madsen, Hvidovre / Cheflæge Michael Dalager-Pedersen, Aalborg. .
Nyt fra tidsskrifterne [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?BMC Infectious Diseases
4.10.2024
. Abstract. . Background and rationale. Methicillin resistant Staphylococcus aureus (MRSA) colonization increases the risk of MRSA infection. Detecting MRSA colonization can influence postoperative outcomes and prolong hospital stay. The conventional standard culture method for detecting MRSA colonization has limitations in terms of sensitivity and turnaround time. Hence, we sought out use of Xpert PCR kit for prompt evaluat…
BMC Infectious Diseases
3.10.2024
. Abstract. . Background and rationale. Methicillin resistant Staphylococcus aureus (MRSA) colonization increases the risk of MRSA infection. Detecting MRSA colonization can influence postoperative outcomes and prolong hospital stay. The conventional standard culture method for detecting MRSA colonization has limitations in terms of sensitivity and turnaround time. Hence, we sought out use of Xpert PCR kit for prompt evaluat…
BMC Infectious Diseases
18.09.2024
…4 to June 2022 and classified them into C. striatum-BSI group and contamination group; Clinical characteristics, treatments, and outcomes were compared between the C. striatum-BSI group and contamination group, Methicillin-resistant Staphylococcus aureus (MRSA)-BSI and Methicillin-resistant Staphylococcus epidermidis (MRSE)-BSI. . . . Results. Fifty-three patients with positive C. striatum blood cultures were identified. Am…
BMC Infectious Diseases
5.09.2024
. Abstract. . Background. The increasing prevalence of methicillin-resistant Staphylococcus aureus (MRSA) strains resistant to non-beta-lactam antimicrobials poses a significant challenge in treating severe MRSA bloodstream infections. This study explores resistance development and mechanisms in MRSA isolates, especially after the first dalbavancin-resistant MRSA strain in our hospital in 2016. . . …
BMC Infectious Diseases
3.09.2024
. Abstract. . Background. The increasing prevalence of methicillin-resistant Staphylococcus aureus (MRSA) strains resistant to non-beta-lactam antimicrobials poses a significant challenge in treating severe MRSA bloodstream infections. This study explores resistance development and mechanisms in MRSA isolates, especially after the first dalbavancin-resistant MRSA strain in our hospital in 2016. . . …
Clinical Microbiology and Infection
17.06.2024
This review aims to explore the characteristics of outbreaks of community-acquired community-onset methicillin-resistant Staphylococcus aureus (CO-MRSA) in low prevalence areas, to understand the factors involved in its rise, and to translate this knowledge into public health policy and further research needs.
International Journal of Infectious Diseases
22.05.2024
…ssue infections, bacteremia, and endocarditis [1,2]. China Antimicrobial Resistance Surveillance System (CARSS) reported a 46% detection rate of S. aureus in 2020 [3]. The study showed that MRSA prevalence ranged from 0% to 73% at 19 sites in the Asia-Pacific region from 2000 to 2016 [3]. Recently, the rate of MRSA infection has been increasing sharply[4], posing a challenge to the health system in terms of difficult therapy, extended length of hospital stay, expanded health costs, and high mortality [4,5].
PLoS One Infectious Diseases
21.05.2024
by M. Gabriela Cabanilla, Michael L. Bernauer, Liana M. Atallah, Matthew J. Briski, Jason Koury, Cecilia M. Thompson, Chelsea N. Rodriguez, Bernadette Jakeman, Thomas F. Byrd . Background Methicillin-resistant Staphylococcus aureus (MRSA) is associated with high mortality rates. Despite antibiotic therapy, persistent bacteremia is challenging to treat. Combination therapy with ceftaroline has emerged as a potential treatment option; however, the optimal duration and clinical implications after bacteremia c…
Clinical Microbiology and Infection
16.05.2024
Gown and glove use as a component of ‘contact precautions’ was first recommended by the United States Healthcare Infection Control Practices Advisory Committee (HICPAC) in 1996 and remains widely adhered to today (1, 2). Despite a lack of randomised trial evidence in support of this practice, donning of gowns and gloves upon entry to the patient area (room or cubicle) continues to be ‘strongly recommended’ when the patient is infected or colonised with pathogens of epidemiological importance and the…
Clinical Microbiology and Infection
15.03.2024
This study aims to evaluate two commercial broth microdilution (BMD) systems, E1-185-100 (Merlin) and FDANDPF (ThermoFisher) for dalbavancin susceptibility testing in comparison with reference broth microdilution assay.
BMC Infectious Diseases
25.02.2024
. Abstract. . Background. While there is a high burden of methicillin-resistant Staphylococcus aureus (MRSA) infections among pediatric patients, studies on the molecular epidemiology of MRSA infections in Korean children since the 2010s are lacking. This study aimed to investigate the molecular genotypes and clinical characteristics of MRSA isolates from children with MRSA bacteremia at Asan Medical Center Children’s Hosp…
Clinical Microbiology and Infection
24.02.2024
Globally, the isolation of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) harbouring both the Panton–Valentine leucocidin (PVL) and toxic shock syndrome toxin 1 (TSST-1) genes is rare. However, we encountered an outbreak of the ST22-PT clone exhibiting this phenotype in Japan. Notably, the TSST-1 gene was duplicated in most of the strains. This study aimed to elucidate the mechanisms underlying this gene duplication.
Antimicrobial Agents And Chemotherapy
21.02.2024
Antimicrobial Agents and Chemotherapy, Ahead of Print.
BMC Infectious Diseases
17.02.2024
… . Aims. We investigated the antibacterial efficacy of Umonium38 and Virkon® against Burkholderia pseudomallei, Escherichia coli, Pseudomonas aeruginosa and Methicillin-Resistant Staphylococcus aureus (MRSA) up to 14 days following treatment. . . . Methods and results. Umonium38 was diluted to 0.5%, 1.0%, 1.5%, 2.0%, 2.5% and 3%, tested against the bacterial strains at v…
BMC Infectious Diseases
16.02.2024
… . Aims. We investigated the antibacterial efficacy of Umonium38 and Virkon® against Burkholderia pseudomallei, Escherichia coli, Pseudomonas aeruginosa and Methicillin-Resistant Staphylococcus aureus (MRSA) up to 14 days following treatment. . . . Methods and results. Umonium38 was diluted to 0.5%, 1.0%, 1.5%, 2.0%, 2.5% and 3%, tested against the bacterial strains at v…
Antimicrobial Agents And Chemotherapy
13.02.2024
Antimicrobial Agents and Chemotherapy, Ahead of Print.
Clinical Microbiology and Infection
11.01.2024
Staphylococcus aureus is a versatile organism, capable of existing as a commensal organism while also possessing pathogenic potential. The emergence of clinically and genetically distinct strains of methicillin-resistant S. aureus (MRSA), termed community-onset MRSA (CO-MRSA), resulted in an epidemic of invasive and skin and soft tissue infections (SSTI) in otherwise healthy individuals without traditional risk factors. Colonization with S. aureus is a risk factor for developing infection and also a source …
Clinical Microbiology and Infection
10.01.2024
Methicillin-resistant Staphylococcus aureus (MRSA) colonization increases infection risk in both patients and healthy individuals. Decolonization therapy has been proven to reduce S. aureus infections, but data on the effectiveness of individual decolonization strategies in community-onset MRSA carriage are scarce.
Aktuelle smitsomme sygdomme [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?Medscape Infectious Diseases
13.02.2024
Researchers who uncovered a fresh class of antibiotics used a new process — explainable AI — that could propel drug discovery. . Medscape Medical News
Statens Serum Institut
11.04.2023
Referencelaboratoriet for Antibiotikaresistens på Statens Serum Institut opgør hvert kvartal antallet af blodforgiftninger forårsaget af MRSA samt dødsfald som følge af disse.
Statens Serum Institut
11.04.2023
Referencelaboratoriet for Antibiotikaresistens på Statens Serum Institut opgør hvert kvartal antallet af blodforgiftninger forårsaget af MRSA samt dødsfald som følge af disse.
Statens Serum Institut
16.02.2023
I 4. kvartal 2022 blev der registreret 12 nye tilfælde af blodforgiftning med MRSA. Tre af patienterne døde. Det viser den seneste opgørelse fra Statens Serum Institut.
Statens Serum Institut
17.12.2022
I 3. kvartal 2022 blev der registreret 18 nye tilfælde af blodforgiftning med MRSA. Tre af patienterne døde. Det viser den seneste opgørelse fra Statens Serum Institut.
Statens Serum Institut
17.08.2022
I 2. kvartal 2022 blev der registreret ni nye tilfælde af blodforgiftning med MRSA. Der var ingen af patienterne, der døde. Det viser den seneste opgørelse fra Statens Serum Institut.
Statens Serum Institut
10.06.2022
I 1. kvartal 2022 blev der registreret 11 nye tilfælde af blodforgiftning med MRSA. Heraf døde tre patienter. Det viser den seneste opgørelse fra Statens Serum Institut.
Medscape Infectious Diseases
28.04.2022
Prosthetic joint surgery infections following emergency femur fracture surgery can be avoided by screening and decolonization. .
Statens Serum Institut
21.02.2022
I 4. kvartal 2021 blev der registreret 11 nye tilfælde af blodforgiftning (bakteriæmi) med MRSA (methicillin-resistente Staphylococcus aureus), hvoraf 5 patienter døde.
Statens Serum Institut
5.01.2022
Forskere fra Statens Serum Institut har vist, at særlige methicillin-resistente Staphylococcus aureus (MRSA) bakterier – nogle af de mest berygtede og frygtede sygdomsfremkaldende mikroorganismer hos mennesker – var tilstede i pindsvin længe inden methicillin kom på markedet i 1959.
Statens Serum Institut
15.11.2021
Referencelaboratoriet for Antibiotikaresistens på Statens Serum Institut opgør hvert kvartal antallet af blodforgiftninger forårsaget af MRSA samt dødsfald som følge af disse.
Eurosurveillance latest updates
16.09.2021
We describe two false-negative results in the detection of meticillin-resistant Staphylococcus aureus (MRSA) of sequence type 398 and spa type t011 using the Cepheid Xpert MRSA NxG assay. The isolates were recovered in late February and early March 2021 from two patients in different hospitals in the northern Netherlands. Variations between the two isolate genomes indicate that this MRSA strain might have been spreading for some time and could have disseminated to other regions of the Netherlands and other …
Statens Serum Institut
15.09.2021
Det er konklusionen i et forskningsprojekt fra Statens Serum Institut, Danmarks Tekniske Universitet og Aarhus Universitet.
Statens Serum Institut
17.08.2021
Referencelaboratoriet for Antibiotikaresistens på Statens Serum Institut opgør hvert kvartal antallet af blodforgiftninger forårsaget af MRSA samt dødsfald som følge af disse.
Statens Serum Institut
17.05.2021
Referencelaboratoriet for Antibiotikaresistens på Statens Serum Institut opgør hvert kvartal antallet af blodforgiftninger forårsaget af MRSA samt dødsfald som følge af disse.
Statens Serum Institut
10.02.2021
Referencelaboratoriet for Antibiotikaresistens på Statens Serum Institut opgør hvert kvartal antallet af blodforgiftninger forårsaget af MRSA samt dødsfald som følge af disse.
Statens Serum Institut
12.11.2020
Referencelaboratoriet for Antibiotikaresistens på Statens Serum Institut opgør hvert kvartal antallet af blodforgiftninger forårsaget af MRSA samt dødsfald som følge af disse.
Statens Serum Institut
29.10.2020
Forskere fra Statens Serum Institut har påvist en bakterievirus, som gør husdyr-MRSA bedre i stand til at sprede sig til raske personer og hospitalspatienter uden kontakt til svin.
Statens Serum Institut
14.08.2020
Referencelaboratoriet for Antibiotikaresistens på Statens Serum Institut opgør hvert kvartal antallet af blodforgiftninger forårsaget af MRSA samt dødsfald som følge af disse.
Statens Serum Institut
4.06.2020
Antallet af personer, der for første gang fik påvist MRSA, var på samme niveau i 2019 som i de tre foregående år.